Spruce Biosciences (SPRB) Revenue & Revenue Breakdown
Spruce Biosciences Revenue Highlights
Latest Revenue (Y)
$10.09M
Latest Revenue (Q)
$1.61M
Spruce Biosciences Revenue by Period
Spruce Biosciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $10.09M | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | - |
Spruce Biosciences generated $10.09M in revenue during NA 2023, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Spruce Biosciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $1.61M | -19.58% |
| 2024-03-31 | $2.00M | -30.65% |
| 2023-12-31 | $2.89M | -6.05% |
| 2023-09-30 | $3.07M | 41.94% |
| 2023-06-30 | $2.17M | 10.23% |
| 2023-03-31 | $1.96M | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | - |
Spruce Biosciences generated $1.61M in revenue during Q2 2024, up -19.58% compared to the previous quarter, and up 81.98% compared to the same period a year ago.
Spruce Biosciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| VECT | VectivBio | $27.34M | $676.00K |
| HOOK | HOOKIPA Pharma | $20.13M | - |
| SPRB | Spruce Biosciences | $10.09M | $1.61M |
| XFOR | X4 Pharmaceuticals | - | $563.00K |
| DAWN | Day One Biopharmaceuticals | - | $20.07M |
| ABOS | Acumen Pharmaceuticals | - | - |
| INZY | Inozyme Pharma | - | - |
| TERN | Terns Pharmaceuticals | - | - |
| ELDN | Eledon Pharmaceuticals | - | - |
SPRB Revenue FAQ
What is Spruce Biosciences’s yearly revenue?
Spruce Biosciences's yearly revenue for 2023 was $10.09M, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. SPRB's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Spruce Biosciences’s quarterly revenue?
Spruce Biosciences's quarterly revenue for Q2 2024 was $1.61M, a -19.58% decrease from the previous quarter (Q1 2024), and a -25.64% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $2M, a -30.65% decrease from the previous quarter (Q4 2023), and a 1.93% increase year-over-year (Q1 2023). SPRB's quarterly revenue for Q4 2023 was $2.89M, a -6.05% decrease from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is Spruce Biosciences’s revenue growth rate?
Spruce Biosciences's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.